戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 sus ATCC 7469 (formerly called Lactobacillus casei).
2 murta berries could act as prebiotics for L. casei.
3 ermentation in the presence of Lactobacillus casei.
4 o each other and to the FLP of Lactobacillus casei.
5  transcription factor FNR than the FLP of L. casei.
6 ingle-species biofilms of C. albicans and L. casei.
7 isteria (Lm) on the surface of Lactobacillus casei.
8 icroencapsulated and co-microencapsulated L. casei.
9  with Streptococcus mutans and Lactobacillus casei.
10 showed strong inhibition to S. mutans and L. casei.
11 ns, Enterococcus faecalis, and Lactobacillus casei.
12 hancers did not constitute an obstacle to L. casei 01 (>10(8)CFU/g) during storage.
13                                           L. casei 01 addition produced several volatile compounds, s
14              The effect of the Lactobacillus casei 01 and inulin addition on sheep milk ice cream dur
15 ic acid bacteria and probiotic Lactobacillus casei 01 counts and survival under gastrointestinal cond
16                     Inulin did not affect L. casei 01 survival after the passage through simulated ga
17                All formulations supported L. casei 01 viability and maintained above the minimum ther
18 Lactobacillus paracasei subsp. paracasei (L. casei 01); QB - with Bifidobacterium animalis subsp. lac
19  L. casei 01, 6logCFU/mL; 10% w/w inulin, L. casei 01, 6logCFU/mL, respectively) were manufactured.
20 eep milk cream; 10% w/w sheep milk cream, L. casei 01, 6logCFU/mL; 10% w/w inulin, L. casei 01, 6logC
21 ional mutagenesis of dltD from Lactobacillus casei 102S.
22 Lactobacillus paracasei subsp. paracasei, L. casei 431 (Chr. Hansen A/S) (hereafter, L. casei 431) on
23 ntaining >/=10(9) colony-forming units of L. casei 431 (n = 553) or placebo (n = 551) for 42 d.
24                    There was no effect of L. casei 431 on immune responses to influenza vaccination.
25                      Daily consumption of L. casei 431 resulted in no observable effect on the compon
26 . casei 431 (Chr. Hansen A/S) (hereafter, L. casei 431) on immune response to influenza vaccination a
27 euconostoc spp. 4454, and Lacticaseibacillus casei 4339.
28 us, Lactobacillus acidophilus, Lactobacillus casei, Actinomyces naeslundii genospecies (gsp) 1 and 2,
29  acid/base residue E274 of the Lactobacillus casei alpha1,6-fucosidase, including E274A, E274S, and E
30 and predicted secondary structures of the L. casei and B. subtilis Dcps with that of the E. coli acyl
31  as well as on single-species biofilms of L. casei and C. albicans, cultured on hydroxyapatite discs.
32 s dihydrofolate reductase from Lactobacillus casei and chicken liver.
33                Melting curves of TSs from L. casei and E. coli are compared to that of TS-A from B. s
34  than LY231514 against TS from Lactobacillus casei and Escherichia coli.
35 dentified as relevant VOCs for Lactobacillus casei and Lactobacillus paracasei subsp.
36 dentified as relevant VOCs for Lactobacillus casei and Lactobacillus paracasei subsp. paracasei.
37 sules was studied in terms of survival of L. casei and release of oil in sequential exposure to simul
38 tobacillus rhamnosus (formerly Lactobacillus casei) and Bacillus subtilis.
39 ndii, Mycobacterium avium, and Lactobacillus casei) and showed good to modest activity against these
40 herichia coli, 35 and 56% with Lactobacillus casei, and 23 and 40% with Thermotoga maritima, respecti
41 carinii, T. gondii, rat liver, Lactobacillus casei, and Escherichia coli, and selected analogues were
42 ariogenic biofilm comprising C. albicans, L. casei, and S. mutans, as well as on single-species biofi
43 4 in Escherichia coli, Y146 in Lactobacillus casei, and Y135 in humans) was assumed to serve as the g
44 d and compared NMR solution structures of L. casei apo DHFR and its binary and ternary complexes with
45  which could not be directly detected for L. casei apo DHFR because of line broadening from exchange
46 sured on assigned signals from Lactobacillus casei apo-DHFR and its binary and ternary complexes with
47  and vancomycin, whereas L. rhamnosus and L. casei are resistant to metronidazole and vancomycin.
48                    We selected Lactobacillus casei as a model microorganism to proceed to genomewide
49  correlate (R = 0.98) with the Lactobacillus casei assay for whole blood folate.
50 olate values obtained with the Lactobacillus casei assay have formed the basis for current ranges and
51 ncreased miR-192 expression, whereas only L. casei association increased miR-200b and miR-215 express
52 robial viability was found by cultivating L. casei at 31 degrees C and pH 5.8 (optimised conditions).
53 L. helveticus DPC 4571 and an increase in L. casei ATCC 334 during ripening.
54 up-regulated during logarithmic growth of L. casei ATCC 334 on sucrose isomers.
55 tion of the genome sequence of Lactobacillus casei ATCC 334 revealed two operons that might dissimila
56         To test this hypothesis, cells of L. casei ATCC 334 were grown in a defined medium supplement
57 cillus helveticus DPC 4571 and Lactobacillus casei ATCC 334) directly or after sonication on the qual
58 id tolerance response (ATR) in Lactobacillus casei ATCC 334.
59 t of the amount of immobilized Lactobacillus casei ATCC 393 on wheat grains on the generation of vola
60 c culture (free or immobilized Lactobacillus casei ATCC 393 on wheat grains) and the ripening time on
61 illus species (L. acidophilus ATCC 53544, L. casei ATCC 393, and L. reuteri ATCC 23272), with the aim
62 us acidophilus (ATCC(R) 4356), Lactobacillus casei (ATCC(R) 393) and Lactobacillus paracasei subsp. p
63 icantly promoted the growth of Lactobacillus casei BCC36987.
64 llus paracasei CNCM I-3689 and Lactobacillus casei BL23, on L. monocytogenes and orally acquired list
65 hages present in the genome of Lactobacillus casei BL23.
66 acillus plantarum CECT 220 and Lactobacillus casei CECT 475) in order to evaluate the ability of SPC
67  KD that involves injection of Lactobacillus casei cell wall extract (LCWE), we investigated the role
68             After injection of Lactobacillus casei cell-wall extract (LCCWE), mice develop a focal co
69 parison reasons, sausages containing free L. casei cells or no starter culture as well as a similar c
70  by the otherwise strong cytokine inducer L. casei CHCC3139, while IL-10 production remained unaltere
71 he microRNA (miR)-23b(-/-) and Lactobacillus casei (Chinese Industrial Microbial Culture Collection C
72 e dihydrofolate reductase from Lactobacillus casei complexed with methotrexate, NADPH and 264 crystal
73 ), or regular calcium + 5 x 10(8) CFU/day L. casei CRL 431 (Casei, n = 60/120).
74  was shown to be a suitable substrate for L. casei cultivation and for the development of an alternat
75                                           L. casei Dcp is 46% identical to the putative product of dl
76 udy is to evaluate the role of Lactobacillus casei DG (LC-DG) and its postbiotic (PB) in modulating t
77 on structure of the complex of Lactobacillus casei dihydrofolate reductase (18.3 kDa, 162 amino acid
78 e X-ray studies of the ternary complex of L. casei dihydrofolate reductase formed with methotrexate a
79 the eight arginine residues in Lactobacillus casei dihydrofolate reductase in its binary complex with
80 ects of heat-killed LAB strain Lactobacillus casei DK128 (DK128) on influenza viruses.
81                     Among drying methods, L. casei enriched FD murta presented less alterations in th
82 t tryptophan 82 mutants of the Lactobacillus casei enzyme produced 5-(2-hydroxyethyl)thiomethyl-dUMP
83 n the crystal structure of the Lactobacillus casei enzyme.
84 lso evaluated as inhibitors of Lactobacillus casei, Escherichia coli, and rat and rh thymidylate synt
85  were evaluated against human, Lactobacillus casei, Escherichia coli, Streptococcus faecium, and Pneu
86 e ternary crystal structure of Lactobacillus casei FPGS.
87 ivo challenge, we identified a core of 47 L. casei genes necessary for its establishment in the gut.
88 , ThiT) were identified in the Lactobacillus casei genome, expressed in Lactococcus lactis, and funct
89 hat provides a representative view of the L. casei genome.
90 g-nu/+ mice were significantly reduced by L. casei GG and B. animalis.
91 philus, Lactobacillus reuteri, Lactobacillus casei GG, and Bifidobacterium animalis) to colonize, inf
92 philus, Lactobacillus reuteri, Lactobacillus casei GG, or Bifidobacterium animalis) in the gastrointe
93 nized with pure cultures of L. reuteri or L. casei GG.
94                                       Vibrio casei had the strongest growth stimulation when exposed
95 st, the N229(177)V mutation in Lactobacillus casei has minimal effect on activity).
96  to the C-terminal fragment of Lactobacillus casei HPrK/P and the C-terminal domain of Staphylococcus
97 ed to B. animalis VKB (1.70 +/- 0.21) and L. casei IMVB-7280 (1.80 +/- 0.20).
98 three probiotic strains (2:1:1 Lactobacillus casei IMVB-7280, Bifidobacterium animalis VKL, Bifidobac
99 obiotics B. animalis VKL, B. animalis VKB, L.casei IMVB-7280, respectively.
100 Using the structure of TS from Lactobacillus casei in complex with the nonsubstrate analogue phenolph
101 ainst Streptococcus mutans and Lactobacillus casei (in both planktonic growth and biofilm formation).
102  In analogous fashion, L. reuteri reduced L. casei-induced up-regulation of B7-2.
103                                           L. casei IUOM-14 did not degrade any of the substrates.
104 e growth of the probiotics L.acidophilus, L. casei, L. plantarum, and L. rhamnosus, resulting in decr
105 da albicans, Escherichia coli, Lactobacillus casei, L. reuteri, L. acidophilus, a Bifidobacterium sp.
106 Three probiotic strains namely Lactobacillus casei, Lactobacillus brevis and Lactobacillus plantarum
107 featured by decreased level of Lactobacillus casei, Lactobacillus johnsonii and increased E. coli.
108                                Lactobacillus casei, Lactobacillus johnsonii, and Lactobacillus delbru
109   According to the literature, Lactobacillus casei, Lactobacillus reuteri, Lactobacillus rhamnosus GG
110  being clinically significant: Lactobacillus casei, Lactobacillus rhamnosus, and Lactobacillus leichm
111 ) in their cross-bridge, such as Lactococcus casei, Lactococcus lactis, and Enterococcus faecium.
112 tobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+)
113 tobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2) within 1
114  jua pulp for fermentation by monoculture L. casei (Lc - 01) and L. acidophilus (La - 05) and co-cult
115 R, Escherichia coli (ec) DHFR, Lactobacillus casei (lc) DHFR and tgDHFR with hDHFR as the mammalian r
116    The analogues 2-4 inhibited Lactobacillus casei (lc) TS and recombinant human (h) TS with IC50 in
117 hs), Escherichia coli (ec) and Lactobacillus casei (lc) were elucidated and compared using intrinsic
118 ell wall extract isolated from Lactobacillus casei (LCCWE) into mice causes a focal coronary arteriti
119             bulgaricus-151 and Lactobacillus casei-LcY were the most advantageous with desirable sens
120  contrast, per 1 unit increase in log(10) L. casei levels, there was a 42 gm increase in birth weight
121 icaseibacillus rhamnosus, Lacticaseibacillus casei, Levilactobacillus brevis, and Propionibacterium f
122 canning electron microscopy revealed that L. casei localized at the peduncle and near the peduncle of
123 ation with a probiotic strain, Lactobacillus casei LOCK 0900, on selected parameters related to prote
124 tested for antibacterial activity against L. casei, M. tuberculosis H37Ra, and three M. avium strains
125 minerals or a probiotic agent (Lactobacillus casei) may impact recurrence rates.
126 /ml (2.27 nM) [(3)H]folic acid in Folic Acid Casei Medium.
127 enolic compounds, which was attributed to L. casei metabolic activity suggesting that murta berries c
128 alcium + 5 x 10(8) CFU/day L. casei CRL 431 (Casei, n = 60/120).
129 ducing a probiotic beverage by Lactobacillus casei NRRL B442.
130 th no effect (p<0.05) of inoculation with L. casei on its level.
131 y 2-3-fold higher than TS from Lactobacillus casei or Escherichia coli.
132            Chickens were given Lactobacillus casei over-expressing myosin-cross-reactive antigen (LC(
133 a (Lactobacillus plantarum and Lactobacillus casei) over 72 h.
134                                Lactobacillus casei produces an alpha-fucosidase, called AlfC, with sp
135  overcomes the barrier that had prevented L. casei random mutagenesis, we developed a signature-tagge
136  D-alanyl-lipoteichoic acid in Lactobacillus casei requires the 56-kDa D-alanine-D-alanyl carrier pro
137  Lactobacillus acidophilus and Lactobacillus casei, respectively.
138 MIZ were not significantly different between Casei, Reuteri, LC compared to RC.
139 ined by microbiological assay (Lactobacillus casei rhamnosus) and tri-enzyme (protease, alpha-amylase
140 can women, commercial vaginal probiotics (L. casei rhamnosus, L. acidophilus) and 4 reference strains
141 d whether an intervention with Lactobacillus casei Shirota (LcS) in elderly nursing home residents re
142 D: +0.46; 95% CI: 0.08, 0.85) but not for L. casei Shirota (SMD: +0.26; 95% CI: -0.30, 0.82).
143 owel movements/wk) but not for Lactobacillus casei Shirota (WMD: -0.2 bowel movements/wk; 95% CI: -0.
144              For single-species biofilms, L. casei showed a significant reduction compared to PC and
145 ics subsp. lactis strain X and Lactobacillus casei strain B extracts had an MIC of 10mg/ml after 48 h
146 films (Actinomyces naeslundii, Lactobacillus casei, Streptococcus mitis, Veillonella parvula, and Fus
147 acillus lactis BCMC(R) 12,451, Lactobacillus casei subsp BCMC(R) 12,313, Bifidobacterium longum BCMC(
148 h of chloramphenicol-resistant Lactobacillus casei subspecies rhamnosus (NCIMB 10463).
149  provided by experiments that showed that L. casei survival at pH 2.5 was improved at least 100-fold
150 st global functional genomics analysis of L. casei symbiosis.
151 ts agree well with those using Lactobacillus casei, the current gold standard reference assay.
152 ary complexes of the wild-type Lactobacillus casei thymidylate synthase enzyme.
153 ment set of 19 mutants at position 221 of L. casei thymidylate synthase.
154 surface hydrophobicity and the ability of L. casei to adhere to the intestinal wall.
155 n synbiotic ice cream and the adhesion of L. casei to Caco-2 cells was observed.
156 ed after low-dose probiotic or Lactobacillus casei treatment, but B7RP-1 showed increased expression
157 imilar to previously described Lactobacillus casei TS inhibition studies with sulfhydryl reagents, th
158          With three C-terminal mutants of L. casei TS, HETM-dUMP formation was consistent with a mode
159 ement set of mutations at position 146 of L. casei TS.
160 native berry, impregnated with Lactobacillus casei var. rhamnosus and dehydrated by different methods
161 enriched with probiotics contained higher L. casei viable counts after dehydration with FD compared t
162 el of KD in which injection of Lactobacillus casei wall extract (LCWE) induces coronary arteritis, we
163    In the bacterial synthesis, Lactobacillus casei was grown in the presence of 1 ng/ml (2.27 nM) [(3
164 ga-3 rich tuna oil and probiotic bacteria L. casei were produced using whey protein isolate-gum Arabi
165 robiotic products (e.g., L. rhamnosus and L. casei) were identical, by 16S rRNA gene sequencing, to o
166  and elicit cytokines and used Lactobacillus casei, which often predominates in deep carious lesions
167  plantarum (WJ-LP), L. rhamnosus (WJ-LR), L. casei (WJ-LC), L. brevis (WJ-LB) and Pediococcus pentosa

 
Page Top